Fascin Controls Metastatic Colonization and Mitochondrial Oxidative Phosphorylation by Remodeling Mitochondrial Actin Filaments.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
10 09 2019
Historique:
received: 29 01 2019
revised: 24 06 2019
accepted: 31 07 2019
entrez: 12 9 2019
pubmed: 12 9 2019
medline: 17 9 2020
Statut: ppublish

Résumé

The deregulation of the actin cytoskeleton has been extensively studied in metastatic dissemination. However, the post-dissemination role of the actin cytoskeleton dysregulation is poorly understood. Here, we report that fascin, an actin-bundling protein, promotes lung cancer metastatic colonization by augmenting metabolic stress resistance and mitochondrial oxidative phosphorylation (OXPHOS). Fascin is directly recruited to mitochondria under metabolic stress to stabilize mitochondrial actin filaments (mtF-actin). Using unbiased metabolomics and proteomics approaches, we discovered that fascin-mediated mtF-actin remodeling promotes mitochondrial OXPHOS by increasing the biogenesis of respiratory Complex I. Mechanistically, fascin and mtF-actin control the homeostasis of mtDNA to promote mitochondrial OXPHOS. The disruption of mtF-actin abrogates fascin-mediated lung cancer metastasis. Conversely, restoration of mitochondrial respiration by using yeast NDI1 in fascin-depleted cancer cells is able to rescue lung metastasis. Our findings indicate that the dysregulated actin cytoskeleton in metastatic lung cancer could be targeted to rewire mitochondrial metabolism and to prevent metastatic recurrence.

Identifiants

pubmed: 31509745
pii: S2211-1247(19)31044-7
doi: 10.1016/j.celrep.2019.08.011
pmc: PMC6759858
mid: NIHMS1539603
pii:
doi:

Substances chimiques

Actins 0
Carrier Proteins 0
DNA, Mitochondrial 0
FSCN1 protein, human 0
Microfilament Proteins 0
Ndi1 protein, S cerevisiae 0
Saccharomyces cerevisiae Proteins 0
Electron Transport Complex I EC 7.1.1.2

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2824-2836.e8

Subventions

Organisme : NCI NIH HHS
ID : R01 CA216853
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA076292
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA036727
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA163649
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA210439
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA233844
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA175741
Pays : United States

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Br J Cancer. 2003 Feb 24;88(4):537-47
pubmed: 12592367
Curr Biol. 2005 Apr 12;15(7):678-83
pubmed: 15823542
Int J Biochem Cell Biol. 2005 Sep;37(9):1787-804
pubmed: 16002322
J Biol Chem. 2006 Jul 14;281(28):19676-87
pubmed: 16687406
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Cell. 2009 Mar 6;136(5):823-37
pubmed: 19269363
PLoS One. 2009 Aug 06;4(8):e6529
pubmed: 19657394
Nature. 2009 Sep 3;461(7260):109-13
pubmed: 19693011
Nature. 2010 Apr 15;464(7291):1062-6
pubmed: 20393565
J Mol Biol. 2010 May 28;399(1):31-40
pubmed: 20398675
J Mol Biol. 2010 Jul 16;400(3):589-604
pubmed: 20434460
Nucleic Acids Res. 2011 Jul;39(12):5098-108
pubmed: 21398640
Cancer Cell. 2011 Jul 12;20(1):92-103
pubmed: 21741599
Science. 2011 Oct 21;334(6054):358-62
pubmed: 21885730
J Biol Chem. 2011 Nov 11;286(45):38865-75
pubmed: 21914811
J Biol Chem. 2011 Nov 11;286(45):38886-93
pubmed: 21937440
Am J Pathol. 2012 Jan;180(1):24-31
pubmed: 22056359
Science. 2011 Nov 25;334(6059):1081-6
pubmed: 22116877
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W127-33
pubmed: 22553367
Methods Mol Biol. 2012;928:221-8
pubmed: 22956145
Oncogene. 2013 Oct;32(40):4814-24
pubmed: 23128392
J Biol Chem. 2013 Jan 4;288(1):274-84
pubmed: 23184945
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
Hum Mol Genet. 2013 Apr 15;22(8):1601-14
pubmed: 23314018
Science. 2013 Jan 25;339(6118):464-7
pubmed: 23349293
BMC Bioinformatics. 2013 May 07;14:153
pubmed: 23647742
Elife. 2013 May 14;2:e00422
pubmed: 23682313
Science. 2013 Jun 28;340(6140):1567-70
pubmed: 23812712
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11863-8
pubmed: 23821750
J Biol Chem. 2013 Dec 27;288(52):36971-82
pubmed: 24235142
Nature. 2014 Jan 16;505(7483):335-43
pubmed: 24429632
Gastroenterology. 2014 May;146(5):1386-96.e1-17
pubmed: 24462734
Curr Biol. 2014 Feb 17;24(4):409-14
pubmed: 24485837
Cancer Res. 2014 May 1;74(9):2455-64
pubmed: 24599125
Nature. 2014 Apr 3;508(7494):108-12
pubmed: 24670634
Cell Rep. 2014 Aug 7;8(3):754-66
pubmed: 25066121
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
J Cell Biol. 2014 Nov 24;207(4):535-48
pubmed: 25404747
J Cell Biol. 2015 Jan 5;208(1):109-23
pubmed: 25547155
Nature. 2015 Apr 23;520(7548):553-7
pubmed: 25642965
Nat Methods. 2015 Jun;12(6):523-6
pubmed: 25938372
Nat Commun. 2015 Jun 17;6:7465
pubmed: 26081695
Cell. 2015 Jul 30;162(3):540-51
pubmed: 26232224
Cell. 2015 Jul 30;162(3):552-63
pubmed: 26232225
Elife. 2015 Aug 25;4:null
pubmed: 26305500
Elife. 2015 Nov 26;4:e11553
pubmed: 26609810
Elife. 2016 Feb 22;5:null
pubmed: 26901439
Curr Protoc Mouse Biol. 2016 Mar 01;6(1):1-14
pubmed: 26928661
Science. 2016 Jul 15;353(6296):aaf5549
pubmed: 27418514
Stem Cells. 2016 Dec;34(12):2799-2813
pubmed: 27502039
Mol Biol Cell. 2016 Oct 15;27(20):3109-3121
pubmed: 27559132
Cell Metab. 2016 Nov 8;24(5):728-739
pubmed: 27746051
J Biol Chem. 2016 Dec 30;291(53):27323-27333
pubmed: 27879315
Cancer Cell. 2017 Jul 10;32(1):71-87.e7
pubmed: 28697344
Nat Med. 2018 Jul;24(7):1047-1057
pubmed: 29892061
J Cell Biol. 1998 Oct 5;143(1):121-33
pubmed: 9763425

Auteurs

Shengchen Lin (S)

Department of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, PA, USA.

Chongbiao Huang (C)

Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.

Venugopal Gunda (V)

Eppley Institute for Research in Cancer and Allied Diseases, Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.

Jianwei Sun (J)

Department of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, PA, USA; State Key Laboratory of Conservation and Utilization of Bio-Resources in Yunnan and Center for Life-Sciences, School of Life Sciences, Yunnan University, Kunming, China.

Srikumar P Chellappan (SP)

Department of Tumor Biology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.

Zengxun Li (Z)

Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.

Victoria Izumi (V)

Department of Molecular Oncology and Proteomics Core, H. Lee Moffitt Cancer Center, Tampa, FL, USA.

Bin Fang (B)

Department of Molecular Oncology and Proteomics Core, H. Lee Moffitt Cancer Center, Tampa, FL, USA.

John Koomen (J)

Department of Molecular Oncology and Proteomics Core, H. Lee Moffitt Cancer Center, Tampa, FL, USA.

Pankaj K Singh (PK)

Eppley Institute for Research in Cancer and Allied Diseases, Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.

Jihui Hao (J)

Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.

Shengyu Yang (S)

Department of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, PA, USA; Department of Tumor Biology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. Electronic address: sxy99@psu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH